Clinical Trial

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
In an investigator initiated multicenter trial (Malmö, Odense, Århus) the investigators aim at evaluating activity of Graves´ophthalmopathy (GO) and progress to severe GO in patients with mild to moderate Graves´ ophthalmopathy treated with simvastatin or no treatment.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2017-04-24; most recent amendment 2024-09-23.
Status change: Not Yet Recruiting → Recruiting 2018-03-01
Trial Details
NCT Number NCT03131726
Lead Sponsor Lund University
Collaborators: Region Skane
Conditions Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy
Enrollment 80 participants
Start Date 2018-01-26
Primary Completion 2027-01-26 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-25